About us

At Y-mAbs, patients are at the heart of everything we do

Like all powerful stories, ours is personal. Founder Thomas Gad launched Y-mAbs in 2015 to help families access cutting-edge therapies like the ones that were used to treat his daughter in her fight against high-risk neuroblastoma. Our heritage focused in pediatric oncology has shown us that targeting some of the most difficult cancers can open up a world of possibilities, enabling us to treat more patients across a variety of diseases and expand access to novel therapies.

Leadership

At Y-mAbs, “easy” isn’t in our DNA. With deep expertise in pediatric and adult oncology, drug development and commercialization, our management team has the experience and dexterity needed to develop comprehensive radioimmunotherapy and antibody-based therapies for notoriously challenging diseases.